The record
Written by software from the 1 report below. The points restate them; where one says why it matters, that is Prism's reading, not a reported fact.
- The US Food and Drug Administration has upgraded a recall for a specific lot of thyroid medication to Class I status, indicating a risk of serious health consequences or death.
- The affected tablets, used to treat hypothyroidism, contain potent hormones that can cause hyperthyroidism if present in excessive amounts.
- Patients using the affected lot are advised not to discontinue use immediately but to contact their healthcare provider for further instructions.
- This action stems from concerns that the product could cause symptoms ranging from heart irregularities to muscle weakness.
Coverage1
1 report
English national1
All filed from India
Named United States · Vitruvias Therapeutics · Food and Drug Administration
The 1 report is listed beside the record.
Corrections and versions
A correction says what was wrong and why. Every earlier headline and brief of this record is kept.
Something wrong?
Say what, and it arrives with this record's address filled in. A correction is welcome.
Ask this story
Answers cite the reports above, or say they can't.